No evidence that protein truncating variants in <i>BRIP1</i> are associated with breast cancer risk: implications for gene panel testingDouglas F. Easton, Montserrat García‐Closas, Fabienne Lesueur et al.|Journal of Medical Genetics|2016Cited by 104
Immune checkpoint inhibitors for POLE or POLD1 proofreading-deficient metastatic colorectal cancerMargherita Ambrosini, Filippo Pietrantonio, Aurélien Marabelle et al.|Annals of Oncology|2024Cited by 73